Major interaction on record — check this product against your medications before combining. Check your meds →
Dietary supplement

A.T.P. 25 mg Ingredients & Drug Interactions

by Montiff

Tablet Or Pill Category: Non-nutrient/non-botanical
Most serious interaction: Major
The interaction bottom line Most serious interaction: Major

A.T.P. 25 mg is a dietary supplement by Montiff with 1 active ingredient. Its ingredients are commonly taken for energy and cellular function support, athletic performance and muscle energy, circulation support.Based on those ingredients, 47 medications have a known interaction with it, the most serious rated major. The ingredients most likely to interact are Adenosine Triphosphate. Use the checker below to test your specific medication, or read the full HelloPharmacist Interaction Report.

HelloPharmacist Scorecard of A.T.P. 25 mg by Montiff

Our pharmacy team’s full take, with four database checks built into the cards below — a summary of what is known, not a grade of the product itself.

From our pharmacy team — supplement deep dive

What’s inside

Full disclosure
Ingredient Transparency · database check
Full

Every active ingredient lists its own amount on the label.

Why this rating?
  • The label discloses an exact amount for 1 of its 1 active ingredient.
  • No proprietary blends here — you can verify the dose of every single component.

A.T.P. 25 mg contains one active ingredient: adenosine triphosphate (ATP), a naturally occurring molecule in your cells that plays a role in energy production and certain heart and blood-vessel functions.

The tablet also includes several inactive ingredients — dicalcium phosphate, cellulose, vegetable stearine, cellulose acetate phthalate, croscarmellose sodium, silica, diethyl phthalate, magnesium stearate, and poloxamer — which serve as binders and fillers to form the tablet.

Does it work?

Not established
Evidence for Intended Use · database check
By FDA rules, dietary supplements can’t claim to treat, cure, or prevent disease — so labels speak in careful marketing language. We discern each product’s intended use from its name, label claims, and label statements, then grade the clinical evidence for that use. How these ratings are computed
Not established

The graded evidence we hold for these ingredients covers different conditions than the ones this product is marketed for, so there's no established rating for its stated use — see Adenosine's own graded uses on its monograph.

Why this rating?
  • The label markets this product for: Energy and cellular function support.
  • We looked for evidence on: Athletic performance, muscle energy, cellular ATP production, exercise performance.
  • The closest evidence on file: Adenosine is rated "Insufficient Reliable Evidence To Rate" for Athletic performance (Natural Medicines).

Adenosine triphosphate is considered effective for paroxysmal supraventricular tachycardia (a type of rapid, irregular heartbeat that starts suddenly) and for cardiovascular disease diagnosis. These ratings come from the prescription injectable form, which is medically powerful and administered only by healthcare professionals.

The data on the oral supplement version that you'd be taking is more limited.

The evidence, ingredient by ingredient Adenosine

How safe is it?

Well-documented data
Safety Information · database check
Well characterized

Adverse-effect, pregnancy, and general safety data are on file for most of these ingredients.

Why this rating?
  • We hold adverse-effect (side-effect) data for 1 of the 1 matched ingredient.
  • Pregnancy & breastfeeding safety ratings cover 1 of 1.
  • General safety write-ups exist for 1 of 1.
  • Remember: this measures how much safety information exists. Thin data is not the same as being safe.

This is where you need to be cautious. The prescription injectable form of adenosine can cause serious cardiovascular and respiratory side effects — chest pain, dizziness, shortness of breath, facial flushing, headache, low blood pressure, nausea, and tingling are common; rare but severe effects include arrhythmias (irregular heartbeats), cardiac arrest, and heart attack.

When adenosine is taken orally or as an intramuscular injection, no adverse effects have been reported, but a thorough safety evaluation hasn't been done. The safety data advises against using this supplement during breastfeeding, and there isn't enough information about safety in pregnancy to know either way — talk with your doctor or pharmacist if you're pregnant, planning to become pregnant, or breastfeeding.

Side effects, ingredient by ingredient Adenosine

Meds to double-check

Major interaction found
Known Interaction Concern · database check
Major identified

At least one ingredient has a documented Major-severity interaction. Check your medications for a personalized result.

Why this rating?
  • 1 of the 1 matched ingredient can interact with medications — Adenosine.
  • The most serious interaction on file is rated Major.
  • For scale: 47 individual medications appear in the full list. A big number alone doesn't make a product dangerous — what matters is whether YOUR medication is on it, so run yours through the interaction checker on this page.

Check with your pharmacist before taking this product if you use dipyridamole (Persantine) — it's a Major interaction and can amplify adenosine's effects. Carbamazepine (Tegretol) is a Moderate concern due to added risk of heart block.

Avoid methylxanthines like caffeine, theophylline, and aminophylline for 24 hours before taking adenosine, as they can block its effects.

Check your own medication Run your meds through the checker above

The bottom line

Scorecard at a glanceFully disclosed formula with no established evidence rating for its marketed use. Major medication interactions have been identified, and safety information is well characterized.

This product is based on a powerful prescription heart medication, and while the oral supplement form hasn't shown reported side effects, the evidence supporting its safety is limited. If you have a heart condition or take any heart or blood-vessel medications — especially dipyridamole, carbamazepine, or caffeine-containing products — check with your pharmacist before starting.

Pregnant or breastfeeding? Talk to your doctor or pharmacist first.

Educational only — not medical advice; always confirm with your pharmacist. Our editorial policy · How we use AI

Assessment coverage: 1 of 1 active ingredient matched to our full ingredient reviews (monographs). Based on the product label dated Dec 21, 2024.

This Scorecard evaluates available label information, ingredient evidence, and known medication-safety considerations. It does not independently verify product identity, purity, potency, contamination, or manufacturing quality. How these ratings are computed

At a glance

General information

Key facts about A.T.P. 25 mg, straight from the product label.

Brand Montiff
Barcode (UPC) 683268103814
Net contents 90 Tablet(s)
Market status On market
Date entered into DSLD Dec 21, 2024
DSLD ID 322083
Product type Non-nutrient/non-botanical
Supplement form Tablet Or Pill
Dietary claims / uses All Other
Intended target group(s) Adult (18 - 50 Years), Sugar Free
From the label
Everything in this section is reproduced from the manufacturer’s own product label — it’s the label speaking, not HelloPharmacist. We show it so you can see exactly what the maker states; we don’t verify or endorse those statements.

Supplement Facts

The label details for A.T.P. 25 mg by Montiff, sourced from the NIH Dietary Supplement Label Database.

Supplement Facts

Daily Value (DV) Target Group(s):
Adults and children 4 or more years of age
Minimum serving Sizes:
1 Tablet(s)
Maximum serving Sizes:
3 Tablet(s)
UPC/BARCODE
683268103814
IngredientAmount% DV
Adenosine Triphosphate25 mg--

Other ingredients: Dicalcium Phosphate, Cellulose, Vegetable Stearine, Cellulose Acetate Phthalate, Croscarmellose Sodium, Silica, Diethyl Phthalate, Magnesium Stearate, Poloxamer

Tap any ingredient to jump to its full detail below.

Label statements
These statements are the manufacturer’s wording, reproduced from the product label — the label is saying it, not HelloPharmacist. We don’t verify or endorse them.
Suggested/Recommended/Usage/Directions

Directions: One to three tablets daily as a dietary supplement, or as directed by a health care professional. Do not take with dairy products.

Precautions

Keep out of the reach of children.

Do not take with dairy products.

Formulation

Formulated without coloring agents, corn, wheat, sugar, starch, yeast, soy, meat products or artificial flavoring

Enteric preparation Highest Quality Available

Formula

Enteric coated tablet designed to dissolve in the small intestine to protect the active ingredient A.T.P..

General Statements

NDC: 65883-381-13

To order call: (310)820-4883

FDA Statement of Identity

Dietary Supplement

See for yourself

A.T.P. 25 mg by Montiff label

The label scan from the NIH Dietary Supplement Label Database. Tap to enlarge.

What’s inside

The Ingredients in A.T.P. 25 mg by Montiff

This is the 1 active ingredient this product is made of. Select it to open its full monograph.

Serving size1 Tablet(s) Dosage formTablet Or Pill Amounts shown are per serving.

Adenosine Triphosphate

Interacts with
47 drugs
25 mg per serving

Adenosine is a natural building block your body uses for energy and cell signaling, and a prescription injectable version is used by doctors to treat...

Adenosine Triphosphate monograph & interactions

Other (inactive) ingredients: Dicalcium Phosphate, Cellulose, Vegetable Stearine, Cellulose Acetate Phthalate, Croscarmellose Sodium, Silica, Diethyl Phthalate, Magnesium Stearate, Poloxamer. These complete the product’s ingredient list but are not active constituents.

Interaction report

A.T.P. 25 mg by Montiff Drug Interactions

Want to check YOUR meds against A.T.P. 25 mg?

Ask about interactions with your drugs in plain English — “Can I take it with lisinopril?” — and we find you the answer in seconds, ingredient by ingredient.

Go to the checker
47Drugs
2 Major 1 Moderate 44 Minor

Ingredients driving the most interactions

Each ingredient & the kinds of drugs it affects

For each ingredient in A.T.P. 25 mg with known interactions, here are the types of medications it can affect. Open any type for the detail — or search your exact drug in the checker above.

Adenosine Triphosphate3 drug types · 47 drugs

Dipyridamole (Persantine)

Dipyridamole can increase the therapeutic and toxic effects of adenosine.
Dipyridamole decreases the metabolism of adenosine. Intravenous infusion of adenosine in patients who are taking dipyridamole can cause dizziness, bradycardia, and syncope. Dipyridamole should be discontinued for several days prior to a cardiac stress test using adenosine.

Likelihood Likely Evidence D
Carbamazepine (Tegretol)

Carbamazepine might increase the risk of heart block when used concomitantly with adenosine.
Carbamazepine and adenosine can both cause heart block. Giving them concurrently might produce an additive effect.

Likelihood Possible Evidence D
Methylxanthines

Methylxanthines are competitive antagonists of adenosine and can block its pharmacologic effects.
The methylxanthines, aminophylline, caffeine, and theophylline, can block the effects of adenosine by acting as competitive antagonists at adenosine cell surface receptors. It is recommended that methylxanthines be avoided for 24 hours prior to cardiac stress tests.

Likelihood Possible Evidence D
The maker

Brand information

Manufacturer and brand details for A.T.P. 25 mg, from the product label.

Montiff

See all Montiff products
Name
Montiff, Inc.
City
Santa Monica
State
CA
ZipCode
90404
Phone Number
(310) 820-4883
Pharmacist Counseling Corner

A.T.P. 25 mg by Montiff: Common Questions

Does A.T.P. 25 mg by Montiff interact with any medications?
Yes. Based on its ingredients, A.T.P. 25 mg has a known interaction with 47 medications, including 2 rated major. Use the checker to see how it interacts with a specific drug.
How can one product interact with so many drugs?
A.T.P. 25 mg contains a single active ingredient, and that one ingredient can interact with many different medications on its own. We check it against each medication and show the mechanism responsible.
Where does this information come from?
The product label data comes from the NIH Dietary Supplement Label Database (DSLD); the interaction data is built on the Natural Medicines database and reviewed by HelloPharmacist pharmacists.
What is adenosine triphosphate, and what does it do in this product?
Adenosine triphosphate (ATP) is a molecule that naturally occurs in your cells and helps with energy production. In this supplement, it's dosed at 25 mg per tablet and is believed to support heart and blood-vessel function — though the evidence for the oral supplement form is more limited than for the prescription injectable version.
Is this supplement safe to take if I'm pregnant or breastfeeding?
The safety data advises against use while breastfeeding. For pregnancy, there isn't enough information to know if it's safe or not. Talk with your doctor or pharmacist for personalized advice if you're pregnant, trying to become pregnant, or nursing.
Can I take this if I drink a lot of coffee or use caffeine supplements?
Caffeine (a methylxanthine) can block the effects of adenosine by competing for the same cell receptors. It's recommended you avoid caffeine and other methylxanthines like theophylline for 24 hours before taking this product.
What are the side effects of this oral supplement?
When adenosine is taken orally, no adverse effects have been reported in the data we have. However, a thorough safety evaluation hasn't been completed, so the full picture of side effects isn't yet clear.
Does this product actually work for heart conditions?
Adenosine triphosphate is considered effective for paroxysmal supraventricular tachycardia (a type of fast, irregular heartbeat) and cardiovascular diagnosis. That said, these ratings come mostly from the prescription injectable form; the evidence for the oral supplement is more limited.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Not sure if A.T.P. 25 mg is safe with your meds?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

Label information is sourced from the NIH Dietary Supplement Label Database and reflects the product version on file; always read your actual product label. This page is for education only and is not a substitute for professional medical advice. Confirm with your pharmacist or doctor before combining supplements and medications.

A.T.P. 25 mg label
Sources

Sources & How We Checked

A.T.P. 25 mg's label data comes from the NIH Dietary Supplement Label Database; the ingredient interaction data is from the Natural Medicines database, reviewed by our pharmacists.

Content is written and reviewed by licensed HelloPharmacist pharmacists. See our data sources and editorial standards for how this information is built and checked.

The 10 references behind this product’s interaction data

Every citation that drives the interaction findings for this product’s ingredients, from the evidence-graded Natural Medicines (TRC Healthcare) database. Open an ingredient to browse its citations — links open the study on PubMed or the publisher’s site.

Adenosine 10 references
  1. McEvoy GK, ed. AHFS Drug Information. Bethesda, MD: American Society of Health-System Pharmacists, 1998.
  2. Agteresch HJ, Dagnelie PC, van den Berg JW, Wilson JH. Adenosine triphosphate: established and potential clinical applications. Drugs 1999;58:211-32.. PubMed
  3. Agteresch HJ, Dagnelie PC, van der Gaast A, et al. Randomized clinical trial of adenosine 5'-triphosphate in patients with advanced non-small-cell lung cancer. J Natl Cancer Inst 2000;92:321-8.. PubMed
  4. Haskell CM, Wong M, Williams A, Lee LY. Phase I trial of extracellular adenosine 5'-triphosphate in patients with advanced cancer. Med Pediatr Oncol 1996;27:165-73.. DOI
  5. Haskell CM, Mendoza E, Pisters KM, et al. Phase II study of intravenous adenosine 5'-triphosphate in patients with previously untreated stage IIIB and stage IV non-small cell lung cancer. Invest New Drugs 1998;16:81-5.. PubMed
  6. Eisenach JC, Curry R, Hood DD. Dose response of intrathecal adenosine in experimental pain and allodynia. Anesthesiology 2002;97:938-42.. PubMed
  7. Agteresch HJ, Dagnelie PC, Rietveld T, et al. Pharmacokinetics of intravenous ATP in cancer patients. Eur J Clin Pharmacol 2000;56:49-55.. PubMed
  8. Underwood DA. Which medications should be held before a pharmacologic or exercise stress test? Cleve Clin J Med 2002;69:449-50. PubMed
  9. Litmann L, Anderson JD, Monroe MH. Adenosine and Aggrenox: A hazardous combination. Ann Intern Med 2002;137:E-76. PubMed
  10. Faghihi G, Iraji F, Rajaee Harandi M, et al. Comparison of the efficacy of topical minoxidil 5% and adenosine 0.75% solutions on male androgenic alopecia and measuring patient satisfaction rate. Acta Dermatovenerol Croat 2013;21(3):155-9.

See these in context on the Adenosine monograph →

Parts of this content are provided by the Therapeutic Research Center, LLC.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Keep exploring